BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
Switch Symbol:
PB Ratio: Premium Valuation
Trending lower, above historical average, modest growth trend.
Left:
||||
Price-to-book ratio
Latest
-3.27
↑ 65% above average
Average (9y)
-9.46
Historical baseline
Range
High:10.43
Low:-64.69
CAGR
+9.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -3.27 | -29.2% |
| 2023 | -2.53 | +65.1% |
| 2022 | -7.24 | +68.8% |
| 2021 | -23.19 | +64.2% |
| 2020 | -64.69 | -720.5% |
| 2019 | 10.43 | +1016.5% |
| 2018 | -1.14 | -73.3% |
| 2017 | -0.66 | +20.4% |
| 2016 | -0.82 | +44.0% |
| 2015 | -1.47 | - |